Objective: To describe cardiorenal risk in Mexican patients with type 2 diabetes (T2D) in primary care. Method: The iCaReMe Global Registry is a prospective, multicenter, observational project designed to provide real-world information on the care of patients with T2D. It is a cross-sectional analysis of the iCaReMe study in a Mexican cohort. Cardiovascular risk (CVR) was stratified using the European Society of Cardiology 2019 guidelines classification. Renal risk was estimated using the urinary albumin-creatinine ratio and the minimum resource model developed by Gendius to predict a reduced glomerular filtration rate. Results: A total of 2,761 patients with T2D were included. Elevated and very elevated CVR was identified in 2,663 (96.4%). Albuminuria was present in 658 (24.6%). In a subgroup, structural and/or functional cardiac abnormalities were reported by echocardiography in 499 (38%). Glycated hemoglobin < 7% was present in 31.1%, and 15.3% were on therapy with cardiorenal benefit. Discussion: A high proportion of patients with T2D in Mexico have a high cardiorenal risk. Health care policies are needed that allow for timely treatment in people at high risk for cardiovascular disease and kidney disease.
Keywords: Type 2 diabetes. Cardiovascular risk. Kidney disease. Primary prevention.
